1. Adjuvant Chemotherapy for T3 Non–Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe 
Michelle C. Salazar, MD, Joshua E. Rosen, BASc, Brian N. Arnold, MD, Daniel C. Thomas, MD, Anthony W. Kim, MD, Frank C. Detterbeck, MD, Justin D. Blasberg, MD, Daniel J. Boffa, MD 
Journal of Thoracic Oncology 
Volume 11, Issue 7, Pages (July 2016)
DOI: /j.jtho
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1
Diagram of study cohort selection steps. Asterisk indicates direct tumor extension to the main bronchus less than 2 cm from the carina, brachial plexus (Pancoast tumor), chest wall, diaphragm, phrenic nerve, mediastinal pleura, or parietal pericardium. NSCLC, non–small cell lung cancer; Postop, postoperatively.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Survival curves for the T3 additional nodule cohort. (A) Kaplan-Meier survival analysis demonstrating 3-year overall survival. (B) Three-year relative survival as a surrogate of cancer-specific survival.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

4. Figure 3
Survival curves for the T3 additional nodule–only cohort. (A) Kaplan-Meier survival analysis demonstrating 3-year overall survival. (B) Three-year relative survival as a surrogate of cancer-specific survival.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions